REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 54 filers reported holding REPLIMUNE GROUP INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -40.0% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | +25.0% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.8% | 200 | +25.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 160 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 160 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 160 | +86.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 86 | -57.2% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 201 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 201 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 201 | -42.6% | 0.00% | – |
| Q4 2018 | $4,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,103,455 | $82,166,000 | 38.87% |
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $45,707,000 | 10.37% |
| Foresite Capital Management IV, LLC | 1,229,656 | $19,797,000 | 6.49% |
| Foresite Capital Management III, LLC | 779,656 | $12,552,000 | 2.77% |
| BVF INC/IL | 911,852 | $14,681,000 | 1.29% |
| Redmile Group, LLC | 2,192,957 | $35,307,000 | 1.09% |
| Cormorant Asset Management, LP | 467,792 | $7,531,000 | 0.49% |
| DC Investments Management, LLC | 39,578 | $637,000 | 0.43% |
| EMERALD ADVISERS, LLC | 618,080 | $9,951,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 523,316 | $8,425,000 | 0.28% |